[1] Quadros, I.G.A. and Gebrim, L.H. (1976) A Pesquisa do linfonodo sentinel para o cancer de mama na prática clínica do ginecologista brasileiro. Revista Brasileira de Ginecologia e Obstetrícia, 29, 158-164.
[2] Matos, A.J.F., Baptista, C.S., Gartner, M.F. and Rutteman, G.R. (2012) Prognostic Studies of Canine and Feline Mammary Tumours: The Need for Starndardized Procedures. The Veterinary Journal, 193, 24-31.
http://dx.doi.org/10.1016/j.tvjl.2011.12.019
[3] Patsikas, M.N., Karayannopolou, E., Kaldrymidoy, L.G., Papazoglou, P.L., Tzegas, S.I., Tziris, N.E., Kaitizi, D.G., Dimitriadis, A.S. and Dessiris, A.K. (2006) The Lymph Drainage of the Neoplastic Mammary Glands in Bich: A Lymphographic Study. Anatomia, Histologia, Embryologia, 35, 228-234.
http://dx.doi.org/10.1111/j.1439-0264.2005.00664.x
[4] Suami, H., Yamashita, S., Soto-Miranda, M.A. and Chang, D.W. (2013) Lymphatic Territories (Lymphosomes) in a Canine: Na Animal Model for Investigation of Postoperative Lymphatic Alterations. Plos ONE, 24, e69222.
http://dx.doi.org/10.1371/journal.pone.0069222
[5] Sakorafas, G.H. and Peros, G. (2007) Sentinel Lymphnode Biopsy in Breast Cancer: What a Physician Should Know, a Decade after Its Introduction in Clinical. European Journal of Cancer Care, 16, 318-321.
http://dx.doi.org/10.1111/j.1365-2354.2006.00762.x
[6] Kelley, M.C., Hansen, N. and Mcmasters, K.M. (2004) Lymphatic Mapping and Sentinela Lymphadenectomy for Breast Cancer. American Journal of Surgery, 188, 49-61.
http://dx.doi.org/10.1016/j.amjsurg.2003.10.028
[7] Zengel, B., Yararbas, U., Sirinocak, A., Ozkok, G., Denecli, A.G., Postaci, H. and Uslu, A. (2013) Sentinel Lymphnode Biopsy in Breast Cancer: Review on Various Methodological Approaches. Tumori, 99, 149-153.
[8] Giuliano, A.E., Hunt, K.K., Ballman, K.V., Beitsch, P.D., Whitworth, P.W., Blumencranz, P.W., et al. (2011) Axilary Dissection vs. No Axilary Dissection in Women with Invasive Breast Cancer and Sentinela Node Metastasis: A Randomized Clinical Trial. Journal of the American Medical Association, 305, 569-575.
http://dx.doi.org/10.1001/jama.2011.90
[9] Veronesi, U., Paganelli, G., Viale, G., Galimberti, V., Luini, A., Zurrida, S., et al. (1999) Sentinel Lymphnode Biopsy and Axillary Dissection in Breast Cancer: Results in a Large Series. Journal of National Cancer Institute, 91, 368-373.
http://dx.doi.org/10.1093/jnci/91.4.368
[10] Raskin, R.E. and Meyer, D.J. (2010) Canine and Feline Cytology: A Color Atlas and Interpretation Guide. 2a Edition, Elsevier, Missouri, 450 p.
[11] Pinheiro, L.G.P., Oliveira Filho, R.S., Vasques, P.H.D., Filgueira, P.H.O., Aragao, D.H.P., Barbosa, P.M.E., Beserra, H.E.O. and Cavalcante, R.V. (2009) Hemosiderin. A New Marker for Sentinel Lymph Node Identification. Acta Cirurgica Brasileira, 24, 432-436.
http://dx.doi.org/10.1590/s0102-86502009000600002
[12] Cassali, G.D., Gobbi, H., Malm, C. and Schitt, F.C. (2007) Evaluation of Accuracy of Fine Needle Aspiration Cytology for Diagnosis of Canine Mammary Tummours: Comparative Features with Human Tumours. Cytopathology, 18, 191-196.
[13] Ensani, F., Enayati, L., Rajabiani, A., Omranipour, R., Alavi, N. and Mosaheb. S. (2013) Improved Detection of Metástases by Step Sectioning and Immuno-Histochemical Staining of Axillary Sentinel Nodes in Patients with Breast Carcinoma. Asian Pacific Journal of Cancer Prevention, 14, 5731-5734.
http://dx.doi.org/10.7314/APJCP.2013.14.10.5731
[14] Schuman, S., Walker, G. and Avisar, E. (2011) Processing Sentinel Nodes in Breast Cancer: When and How Many. Archive Surgery, 146, 389-393.
http://dx.doi.org/10.1001/archsurg.2011.29
[15] Santos, A.A., Lopes, C.C., Ribeiro, J.J., Martins, L.R., Santos, J.C., Amorim, I.F., Gartner, F. and Matos, A.J. (2013) Identification of Prognostic Factors in Canine Mammary Malignant Tumours: A Multivariable Survival Study. BMC Veterinary Research, 9, 1.
http://dx.doi.org/10.1186/1746-6148-9-1
[16] Matos, A.J.F., Lopes, C., Carvalheira, J., Santos, M., Rutteman, G.R. and Gartner, F. (2006) E-Cadherin Expression. In Canine Malignant Mammary Tummours: Relationship to Other Clinic-Pathological Variables. Journal of Comparative Pathology, 134, 182-189.
http://dx.doi.org/10.1016/j.jcpa.2005.10.004
[17] Pinheiro, L.G.P., Moraes, M.O., Soares, A.H., Lopes, A.J.T., Naguere, M.A.S.P., Gondim, F.A.L., Brandao, C.B., Nascimento, D.C.H., Soares, J.P.H. and Silva, J.M.M. (2003) Estudo experimental de linfonodo sentinela na mama de cadela com azul patente e Tecnécio Tc99m. Acta Cirúrgica Brasileira, 18, 514-517.
http://dx.doi.org/10.1590/S0102-86502003000600006
[18] Melo, J.R.M. and Pinheiro, L.G.P. (2010) Linfonodo Sentinela: Importancia na cirurgia do cancer gástrico e perspectiva da aplicacao de um modelo experimental em caninos. Arquivos Brasileiros de Cirurgia Digestiva, 23, 192-195.
http://dx.doi.org/10.1590/s0102-67202010000300012
[19] Aquino, J.U., Pinheiro, L.G.P., Vasques, P.H.D., Rocha, J.I.X., Cruz, D.A., Beserra, H.E.O. and Cavalcante, R.V. (2012) Experimental Canine Model for Sentinel Lymph Node Biopsy in the Vulva Using Technetium and Patent Blue Dye. Acta Cirurgica Brasileira, 27, 102-108.
http://dx.doi.org/10.1590/S0102-86502012000200002
[20] Brenet, O., Lalourcey, L., Queinnec, M., Dupoiron, D., Jayr, C., Rosay, H., Mavoungou, P., Monnin, D., Ancel, B., Maget, B., Louvier, N. and Malinovsky, J.M. (2013) Hypersensitivity Reactions to Patent Blue V in Breast Cancer Surgery: A Prospective Multicentre Study. Acta Anaestesiology Scandinavica, 57, 106-111.
http://dx.doi.org/10.1111/aas.12003
[21] Cassali, G.D., Lavallle, G.E., de Nardi, A.B., Ferreira, E., et al. (2011) Consensus for the Diagnosis, Prognosis and Treatment of Canine Mammary Tumors. Brazilian Journal Veterinary Pathology, 4, 153-180.
[22] Misdorp, W. (2002) Tumors of the Mammary Gland. Blackwell, Ames.
[23] Schloppmann, S.F., Birner, P. and Stuner, P. (2001) Lymphatic Microvessel Density and Lymphovascular Invasion Assessed by Anti-Podoplanin Immunostaining in Human Breast Cancer. Anticancer Research, 21, 2351-2355.
[24] El-Gohary, Y.M, Metwally, G., Saad, R.S., Robinson, M.J., Mesko, T. and Poppiti, R.J. (2008) Prognostic Significance of Intratumoral and Peritumoral Lymphatic Density and Blood Vessel Density in Invasive Breast Carcinomas. American Journal of Clinical Pathology, 129, 578-586.
http://dx.doi.org/10.1309/2HGNJ1GU57JMBJAQ
[25] Shibata, M.A., Ambati, J., Shibata, E., Yoshidome, K. and Harada-Shiba, M. (2012) Mammary Cancer Gene Therapy Targeting Lymphangiogenesis: VEGF-C siRNA and Soluble VEGF Receptor-2, a Splicing Variant. Medical Molecular Morphology, 45, 179-184.
http://dx.doi.org/10.1007/s00795-012-0576-5
[26] Pereira, C.T., Marques, F.L.N., Williams, J., Martin, B.W. and Bombonato, P.P. (2008) 99MTc-Labeled Dextran for Mammary Lymphoscintigraphy in Dogs. Veterinary Radiology & Ultrasound, 49, 487-491.
http://dx.doi.org/10.1111/j.1740-8261.2008.00414.x
[27] Sorenmo, K.U., Rasotto, R., Zappulli, V. and Goldschmidt, M.H. (2011) Development, Anatomy, Histology, Lymphatic Drainage, Clinical Features, and Cell Differentiation Markers of Canine Mammary Gland Neoplasms. Veterinary Pathology, 48, 85-97.
http://dx.doi.org/10.1177/0300985810389480
[28] Szczubial, M. and Lopuszynski, W. (2011) Prognostic Value of Regional Lymphnode Status in Canine Mammary Carcinomas. Veterinary and Comparative Oncology, 9, 296-303.
http://dx.doi.org/10.1111/j.1476-5829.2011.00268.x
[29] Goyal, A., Newcombe, R.G., Chhabra, A. and Mansel, R.E. (2006) Factors Affecting Failed Localization and False- Negative Rates of Sentinela Node Biopsy in Breast Cancer Results of the ALMANAC Validation Phase. Breast Cancer Research Treatment, 99, 203-208.
http://dx.doi.org/10.1007/s10549-006-9192-1
[30] Sobin, L.H. and Wittekind, C.H. (2002) TNM Classification of Malignant Tumours. Wiley, New York.